Publication | Closed Access
Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer
96
Citations
30
References
2006
Year
Candesartan exerted preventive effects on HRPC, rather than on androgen-sensitive PCa, through the inhibition of tumor angiogenesis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1